MedWatch

Demant CEO's wages barely changed in Covid-stricken year

In 2020, Demant President & CEO Søren Nielsen's basic payment dropped a little, whereas his share-based compensation rose, securing him the barest hint of a pay raise.

Demant CEO Søren Nielsen | Photo: Niels Hougaard/ERH

Demant's top executive, Søren Nielsen, had a pay raise of about 0.7 percent last year, according to the Danish hearing aid firm's 2020 fiscal report, published Tuesday morning.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs